Drug Database
Back to search

Poland· PL-100292689

Vermox

A mebendazole product containing mebendazolum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.

ATC P02CA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVermoxATCP02CA01REGISTER NO.PL-100292689PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mebendazolumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mebendazole is registered in 14 of 19 countries.

Countries holding a registration under ATC P02CA01 (mebendazole), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search mebendazole products by name

Mebendazole · ATC P02CA01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Mebendazolum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
P02CA01
ATC class
Mebendazole
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909997217963

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

10 interactions on record for mebendazole.

Graded by severity as the source publishes them — 9 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check mebendazole against other medicinesHow interaction checks work

Mebendazole · interactions on record

10 records

  • 9 moderate
  • 1 minor

Most severe, free to view

  • MetronidazoleJ01XD01moderate
  • RitonavirJ05AE03moderate
  • PhenobarbitalN03AA02moderate
  • PrimidoneN03AA03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mebendazole in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mebendazole products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Pantelmin
  • Belgium · Vermox
  • Cyprus · Thelmox, Vermox
  • Czechia · Vermox
  • Germany · Vermox, Vermox Forte
  • Denmark · Vermox
  • Estonia · Mebendazole Grindeks, Vermox
  • Spain · Lomper
  • United Kingdom (Northern Ireland) · Boots 2 Years Plus Threadworm, Boots Threadworm
  • Greece · Vermox
  • Hungary · Vermox
  • Ireland · Vermox
  • Iceland · Vermox
  • Italy · Vermox
  • Lithuania · Vermox
  • Luxembourg · Vermox
  • Latvia · Mebendazole Grindeks, Vermox
  • Malta · Vermox
  • Netherlands · Idyl Wormkuurtabletten Mebendazol Nederlandse Drogisterij Service, Livsane Wormkuurtabletten
  • Norway · Vermox
  • Portugal · Ceverme, Pantelmin
  • Romania · Permazole, Vermox
  • Sweden · Vermox
  • Slovakia · Vermox

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bbe60181-c631-480f-b00b-cef59e2522ad
GET /v1/drugs/bbe60181-c631-480f-b00b-cef59e2522ad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "100 mg",
  "packaging": "05909997217963 ¦ Rp ¦ 82060\n6 tabl.",
  "substance": null,
  "common_name": "Mebendazolum",
  "pl_product_id": "100292689",
  "pozwolenie_nr": "816/12",
  "auth_procedure": "IR",
  "authorisation_validity": "2027-12-12"
}
API referenceMCP serverPlans

See everything about mebendazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console